Drug Trial Radar · NCT00858364
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Last checked: Nov 20, 2026Latest source record: Nov 30, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
2,549
Actual
Start
Jul 17, 2009
Primary completion
Jun 7, 2017
Study completion Jun 7, 2017
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Mar 9, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Supportive care
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study in patients with chemotherapy induced anemia receiving multi-cycle chemotherapy for the treatment of stage IV non-small cell lung cancer (NSCLC). The primary objective of the study is to demonstrate that overall survival (OS) is not worse in participants on darbepoetin alfa treated to a hemoglobin ceiling of 12.0 g/dL compared to participants treated with placebo.
Conditions
- Non-Small Cell Lung Cancer
- Anemia
- Cancer
- Lung Cancer
Interventions
Darbepoetin alfaDrug
Administered subcutaneously once every 3 weeks
PlaceboDrug
Administered subcutaneously once every 3 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: From randomization until death or end of study; maximum time on follow-up was 93.6 months.
Locations
566 sites in 37 countries. Site status is shown where the registry gives one.
Research Site
Anniston, Alabama
Research Site
Birmingham, Alabama
Research Site
Anchorage, Alaska
Research Site
Tucson, Arizona
Research Site
Fayetteville, Arkansas
Research Site
Hot Springs, Arkansas
Research Site
Jonesboro, Arkansas
Research Site
Little Rock, Arkansas
Research Site
Anaheim, California
Research Site
Arcadia, California
Research Site
Berkeley, California
Research Site
Burbank, California
Research Site
Downey, California
Research Site
Fountain Valley, California
Research Site
Fresno, California
Research Site
Fresno, California
Research Site
La Verne, California
Research Site
Lancaster, California
Research Site
Long Beach, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Merced, California
Research Site
Mission Hills, California
Research Site
Montebello, California
Research Site
Oxnard, California
Research Site
Palm Springs, California
Research Site
Pismo Beach, California
Research Site
Pomona, California
Research Site
Redlands, California
Research Site
Salinas, California
Research Site
San Diego, California
Research Site
Santa Rosa, California
Research Site
Simi Valley, California
Research Site
Soquel, California
Research Site
St. Helena, California
Research Site
Torrance, California
Research Site
Vallejo, California
Research Site
West Covina, California
Research Site
Denver, Colorado
Showing 40 of 566 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.